# Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization

> **NCT06957496** · NA · COMPLETED · sponsor: **Inmunotek S.L.** · enrollment: 31 (actual)

## Conditions studied

- Allergy Pollen
- Allergic Reaction
- Allergic Skin Reaction

## Interventions

- **OTHER:** Allergenic extracts

## Key facts

- **NCT ID:** NCT06957496
- **Lead sponsor:** Inmunotek S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-09
- **Primary completion:** 2025-01-13
- **Final completion:** 2025-01-16
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06957496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06957496, "Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06957496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*